Name | Title | Contact Details |
---|
As one of the world`s premier cancer centers, Memorial Sloan Kettering Cancer Center is committed to exceptional patient care, leading-edge research, and superb educational programs. The close collaboration between our physicians and scientists is one of our unique strengths, enabling us to provide patients with the best care available today as we work to discover more effective strategies to prevent, control, and ultimately cure cancer in the future. Our education programs train future physicians and scientists, and the knowledge and experience they gain at Memorial Sloan Kettering has an impact on cancer treatment and the biomedical research agenda around the world.
The all-in-one digital solution for gut health and disease. We`re helping people feel better, while lowering their cost of care. At Vivante, we`re taking on digestive disease because an astonishing 70 million people in the US are affected—that`s twice the number with diabetes and more than many other chronic conditions combined. Unlike other chronic conditions, though, digestive diseases are often untreated or misdiagnosed...because of stigma. Over half of adults with digestive trouble admit they haven`t even consulted a provider about their symptoms. This is unfortunate because chronic digestive symptoms take a toll on home life, work performance, romance, and even simple social events. And digestive disease is expensive! For most companies, GI claims are the #2 healthcare expense, second only to cancer. Specialty drugs for inflammatory bowel disease can run $70k per year for just ONE employee. Now is the time for employers and health plans to address digestive health, while at the same time providing REAL help to the millions who are struggling and don`t know where to turn. Our all-in-one digital program, GIThrive®, empowers people—through brilliant technology and advanced science—to spend less time worrying about their digestive symptoms and more time living life. A wonderful byproduct of the GIThrive success is reduced medical and Rx drug spending for employers, health plans and individuals.
The Company was founded in April 1997 by Robert Rosenbluth and Brian Cox and incorporated as MicroVention, Inc. in September.
Virginia Premier Health Plan, Inc. is a Health Maintenance Organization (HMO, IPA model), which began operations as a full service Medicaid HMO in August 1995. VPHP is contracted with the Virginia Department of Medical Assistance Services to provide
Ascendis Pharma is focused on creating drug candidates that are improved versions of existing drugs, yielding more effective, lower-risk drugs with new patent life. Our proprietary TransCon platform is the leading, most versatile transient conjugation technology and is utilized to create clinically superior prodrugs in therapeutic areas characterized by high unmet medical need. TransCon technology creates novel long acting prodrugs of proteins, peptides and small molecules, suitable for either local or systemic treatment. Ascendis Pharma has a diversified and balanced high-value pipeline, including internal programs and partnerships together with market leaders on their key projects.